Sharon Riddler News Today

New research shows a quick-dissolving, rectal suppository designed to prevent HIV infection is safe, although its efficacy remains to be tested in clinical trials, some of which will be conducted in South Africa. Still, the findings released late on Tuesday could herald the start of a new ‘take...

Phase 1 study is among first to examine mRNA technology for HIV.

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial

Will mRNA vaccines protect against HIV? Three investigational mRNA vaccines, all designed to combat HIV, have entered Phase I testing.

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform—a technology used in several approved COVID-19 vaccines.

Ridofranz/iStock By DR. DIVYA CHHABRA, ABC News (NEW YORK) — Marc Wagner is a researcher and activist who has been living with HIV for 35 years. He is one of hundreds of HIV-positive people participating in clinical trials for COVID-19 vaccines. “I’m glad that I participated, that it led to the body of knowledge,” he said. But being a part of the vaccine trials was not always an option for him or the 1.2 million HIV-positive people in the U.S. They fought for it. HIV is a lifelong infe...